Anticoagulant use in the pregnancy-puerperal cycle and related adverse effects: literature review
DOI:
https://doi.org/10.33448/rsd-v11i13.35562Keywords:
Anticoagulants; Adverse effects; Pregnancy; Venous thromboembolism.Abstract
Venous thromboembolism is the third most frequent acute cardiovascular disease, where women are at greater risk of developing the disease at childbearing age, and pregnant women are at up to five times greater risk of developing it. This study aims to review the literature regarding the use of anticoagulants in the pregnancy-puerperal cycle and related adverse effects. As a methodology, the platforms MEDLINE/PUBMED, SCIELO, Ministry of Health and book were used, which after exclusion and inclusion criteria, resulted in 25 articles and 1 book included in this study. The results obtained showed that prophylaxis and drug treatment in the pregnancy-puerperal cycle are Low Molecular Weight Heparins and Unfractionated Heparins, but the gold standard of treatment is Low Molecular Weight Heparins. And in extreme cases, Vitamin K Antagonists should be used. Previous research has shown that Direct Oral Anticoagulants should be avoided during the pregnancy-puerperal cycle, as there are still gaps in the knowledge of the risks and benefits of using this class.
References
Azenkot, T. & Schwarz, E. B. (2022). Special Considerations for Women of Reproductive Age on Anticoagulation. Journal of general Internal Medicine, 37(11), 2803-2810.
Bai, W., Zhang, X., Sun, S., Wang, Q., Li, C., Zhang, X. & Zhao, A. (2021). Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study. BMC Pregnancy Childbirth, 21(1), 1-9.
Brandão, G., M., S., Cândido, R. C .F., Rollo, H. de A., Sobreira, M. L. & Junqueira, D. R., (2018). Anticoagulantes orais diretos para o tratamento da trombose venosa profunda: revisão de revisões sistemáticas. Jornal Vascular Brasileiro, 17(4), 310-317.
Brasil. Ministério da Saúde. (2021). Portaria Conjunta N° 12, de 21 de dezembro de 2021. https://www.gov.br/saude/pt-br/assuntos/pcdt/arquivos/portal-portaria-conjunta-no-23-_pcdt_trombofilia_gestantes-republicacao_.pdf/view
Costa, M. T., Ferreira, G .M. & Barros, L. M. (2021). Trombose Venosa Profunda relacionada ao ciclo gravídico-puerperal e alterações fisiopatológicas com o advento do COVID-19. Research, Society and Development, 10(15), 1-10.
Dado, C. D., Levinson, A. T. & Bourjeily, G. (2018). Pregnancy and Pulmonary Embolism. Clin Chest Med., 39(3), 525-537.
Elango, K., Javaid, a., Khetarpal, B. K., Ramalingam, S., Kolandaivel, K. P., Gunasekaran, K. & Ahsan, C. (2021). The effects of warfaroin and direct oral anticoagulants on Systemic Vascular Calcification: A review. Cells, 10(4), 773.
Evangelista, M. S., Slompo, K. & Timi, J. R. R. (2018). Venous Thromboembolism and route of delivery - review literature. Rev Bras Ginecol Obstet, 40(03), 156-162.
Galvão, M. C .B. & Ricarte, I. L .M. (2019). Revisão sistemática da Literatura: conceituação, produção e publicação. Logeion: Filosofia da informação, 6(1), 57-73.
Guimarães, B., Gonçalves. L. R. & Mansilha, A. (2017). Anticoagulantes orais diretos: um novo paradigma no tratamento da trombose venosa profunda. ACV jornal, 13(2), 62-80.
Harter, K., Levine, M. & Henderson, S. (2015). Anticoagulation Drug Therapy: A review. West J Emerg Med, 16(1), 11-17.
Hobohm, L., Farmakis, I.T., Munzel, T., Konstantinides, S. & Keller, K. (2022). Pulmonary Embolism and PRegnancy-Challenges in Diagnostic adn Therapeutic Decisions in High-Risk Patientes. Frotiers in cardiovascular medicine, 9, 856594.
Huang, Y., Li, F., Li, C. & Liao, X. (2022). Efficacy of low molecular Weight heparina in Preventing Perinatal Venous Thrombosis: a meta-analysis. Computational And Mathematical Methods In Medicine, 2022, 1-9.
Jacobson, B., Rambiritch, V., Paek, D., Sayre, T., Naidoo, P., Shan, J. & Leisegang, R. (2020). Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. Adv Ther, 37(1):27-40.
Kalaizopoulos, D. R., Panagopoulus, A., Samant, S., Ghalib, N., Kadillari, J., Daniilid, A., Samartiz, N., Makadia, J., Palaiodimos, L., Kokkinidis, D. G. & Spyrou, N. (2022). Management of venous thromboembolism in pregnancy. Thrombosis research, 211(2022), 106-113.
Mendonca, M. M .V., Santos, A. C. de F., Mendes, A. C. R., Guimarães, B. A., Ribeiro, G .A., Andrade, I. A. de Potsch, L.S ., Jesus, L. S., Nicolau, L. F. M. & Parreira, M. L. B .Q. C. (2021). A incidência de tromboembolismo venoso em gestantes e no puerpério e seus fatores de risco. Revista Eletrônica Acervo Científico, 30, 1-6.
Middeldorp, S., Naue, C. & Kohler, C. (2022). Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?. Hamostaseolohie, 42(01), 054-064.
Mohzari, Y. A, Asdag, S., Bamogaddam, R. F., Alattas, K., Asalmi, S. & alshuraim, R. A. (2021). Postpartum prophylaxis of venous thromboembolism with anticoagulantion: A case report. Journal of Taibah University Medical Sciences, 16(2), 292-294.
Pontes, D. M., Pimentel, L. G. B. & Carvalho, F. H. C. (2013). Eventos tromboembólicos na gestação e puerpério: revisão sistemática e recomendação atual. Femina, 41(1), 9 - 16.
Sanches, S. M. V., Cerqueira, M. M. B.da F., Junqueira, P. L. & Gomes, M. T. (2020). Thromboprophylaxis during the pregnancy-puerperal cycle - literature review. Revista Brasileira de Ginecologia e Obstetricia/Rbgo Gynecology and Obstetrics, 42(04), 218-227.
Scarabelli, I. & Esteves, A. P. V. dos S. (2020). Fenômenos trombolíticos: profilaxia durante o ciclo gravídico puerperal. Cadernos da Medicina - Editora UNIFESO, 3(1), 88-97.
Souza, A .R., Barreira, R. & Santos, E. (2018). Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome. BMJ case reports, 2018, bcr2017223159.
Solati, F. & Varacalo, M. (2022). Low Molecular Weight Heparin (LMWH). https://www.ncbi.nlm.nih.gov/books/NBK525957/
Sucker, C. (2020). Prophylaxis and therapy of venous thrombotic events (VTE) in pregnancy and the postpartum period. Geburtshilfe und fraauenheilkunde, 80(1), 48-59.
Voicu, D. I., Munteanu, O., Gherghiceanu, F., Arsene, L. V., Bohiltea, R .E., Gradinaru, D. M. & Cirstoiu, M. M. (2020). Maternal inherited thrombophilia and pregnancy outcomes. Experimental and therapeutic medicine, 20(3), 2411 - 2414.
Zago, M. A., Falcão, R. P., Pasquini, R., Spector, N.V., Cavas, D. T & Rego, E. M. (2013) Tratado de hematologia. Editora Atheneu.
Witt, D. M., Clark, N. P., Kaatz, S., Schnurr, T. & Ansell, J. E. (2016). Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis, 41(1), 187-205.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Adriane Lima Sales; Jaiza Glória dos Santos Costa; Adrielle Aquino da Silva; Omero Martins Rodrigues Junior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
